Schonfeld Strategic Advisors’s Drugs Made In America Acquisition Corp. Rights DMAAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$49.8K Buy
414,492
+214,492
+107% +$25.8K ﹤0.01% 1787
2025
Q1
$26K Buy
+200,000
New +$26K ﹤0.01% 1964